# Combined Biological Treatment and Chemotherapy for Patients With Inoperable Cholangiocarcinoma

> **NCT00779454** · PHASE2 · COMPLETED · sponsor: **Vejle Hospital** · enrollment: 72 (actual)

## Conditions studied

- Cholangiocarcinoma

## Interventions

- **DRUG:** Gemcitabine, Oxaliplatin, Capecitabine,
- **DRUG:** Panitumumab, Gemcitabine, Oxaliplatin, Capecitabine

## Key facts

- **NCT ID:** NCT00779454
- **Lead sponsor:** Vejle Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2020-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00779454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00779454, "Combined Biological Treatment and Chemotherapy for Patients With Inoperable Cholangiocarcinoma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00779454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*